Sommaire

• • ·Table of contents

    Page :A1

    
• • ·Editorial board

    Page :A6

    
• • ·Information for authors

    Page :A7

    
• • ·Information for readers

    Page :A9

    

• Editorial

  • ·Door-to-needle time in myocardial infarction: Is there an ideal benchmark?

    Page :365-367

    John G. Canto, Catarina I. Kiefe

     
  • ·Delay in acute myocardial infarction: Why don't they come to the hospital more quickly and what can we do to reduce delay?

    Page :368-370

    Russell V. Luepker

     
  • ·To score or not to score?

    Page :371-372

    Véronique L. Roger

    Plan Plan

• Trial Design

  • ·Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention

    Page :373-384

    Timothy D. Henry, Barbara Tate Unger, Scott W. Sharkey, Daniel L. Lips, Wesley R. Pedersen, James D. Madison, Michael R. Mooney, Bjorn P. Flygenring, David M. Larson

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Enoxaparin versus tinzaparin in non–ST-segment elevation acute coronary syndromes: Results of the enoxaparin versus tinzaparin (EVET) trial at 6 months

    Page :385-391

    Christos Katsouras, Lampros K. Michalis, Nikos Papamichael, Kostas Adamides, Katerina K. Naka, Dimitris Nikas, John A. Goudevenos, Dimitris A. Sideris

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :391

    
  • ·Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: Experience in 4 US communities from 1987-2000

    Page :392-400

    Aileen P. McGinn, Wayne D. Rosamond, David C. Goff, Herman A. Taylor, J. Shawn Miles, Lloyd Chambless

    Résumé Résumé Plan Plan  
  • ·A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

    Page :401.e1

    Deepak L. Bhatt, Keith A. Fox, Werner Hacke, Peter B. Berger, Henry R. Black, William E. Boden, Patrice Cacoub, Eric A. Cohen, Mark A. Creager, J. Donald Easton, Marcus D. Flather, Steven M. Haffner, Christian W. Hamm, Graeme J. Hankey, S. Claiborne Johnston, Koon-Hou Mak, Jean-Louis Mas, Gilles Montalescot, Thomas A. Pearson, P. Gabriel Steg, Steven R. Steinhubl, Michael A. Weber, Joan Booth, Eric J. Topol, on behalf of the CHARISMA Investigators 1

    Résumé Résumé Plan Plan  
  • ·Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non–ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study

    Page :401.e9

    Mario Leoncini, Anna Toso, Mauro Maioli, Francesco Bellandi, Toni Badia, Alessandro Politi, Stefano De Servi, Roberto Piero Dabizzi

    Résumé Résumé Plan Plan
  • ·Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients

    Page :402-410

    Saif S. Rathore, Kevin P. Weinfurt, JoAnne M. Foody, Harlan M. Krumholz

    Résumé Résumé Plan Plan  
  • ·A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rationale and initial results of the HIJAMI Registry

    Page :411-418

    Hiroshi Kasanuki, Takashi Honda, Kazuo Haze, Tetsuya Sumiyoshi, Toshinobu Horie, Masahiro Yagi, Jun-ichi Yamaguchi, Yasuhiro Ishii, Shin-ya Fujii, Michitaka Nagashima, Hisayuki Okada, Hiroshi Koganei, Ryo Koyanagi, Yukio Tsurumi, Hirotaka Kimura, Hiroshi Ogawa, for the HIJAMI Investigators Tokyo, Kumamoto, Osaka, and Saitama, Japan

    Résumé Résumé Plan Plan
  • ·Association between lipid testing and statin therapy in acute myocardial infarction patients

    Page :419-425

    Dennis T. Ko, David A. Alter, Alice M. Newman, Linda R. Donovan, Jack V. Tu

    Résumé Résumé Plan Plan  
  • ·Effects of eplerenone versus losartan in patients with low-renin hypertension

    Page :426-433

    Myron H. Weinberger, William B. White, Luis-Miguel Ruilope, Thomas M. MacDonald, Robert C. Davidson, Barbara Roniker, Jeffrey L. Patrick, Scott L. Krause

    Résumé Résumé Plan Plan  
  • ·Long-term hormone replacement therapy does not cause increased platelet activation

    Page :434-438

    Marlene S. Williams, Dhananjay Vaidya, Thomas Kickler, Pamela Ouyang

    Résumé Résumé Plan Plan  
  • ·Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: The Prospective P²C² HIV Multicenter Study

    Page :439-447

    Stacy D. Fisher, Kirk A. Easley, E. John Orav, Steven D. Colan, Samuel Kaplan, Thomas J. Starc, J. Timothy Bricker, Wyman W. Lai, Douglas S. Moodie, George Sopko, Steven E. Lipshultz, for the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group

    Résumé Résumé Plan Plan  
  • ·Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000

    Page :448-454

    David W. Brown, Gail A. Haldeman, Janet B. Croft, Wayne H. Giles, George A. Mensah

    Résumé Résumé Plan Plan  
  • ·Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: Insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

    Page :455-458

    Rabeea Aboufakher, Arthur Riba, Sandeep M. Jani, Raj Goswami, Steven Schwartz, Sandra Lins, Julius Gardin, Dean E. Smith, Eva Kline-Rogers, David Share, Mauro Moscucci, for The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), University of Michigan Medical Center, Ann Arbor, Mich

    Résumé Résumé Plan Plan
  • ·A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy

    Page :459-463

    Hossein Ardehali, David L. Howard, Arvin Hariri, Atif Qasim, Joshua M. Hare, Kenneth L. Baughman, Edward K. Kasper

    Résumé Résumé Plan Plan  
  • ·Association of ?-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS)

    Page :464-470

    Jeannie D. Chan, Thomas D. Rea, Nicholas L. Smith, David Siscovick, Susan R. Heckbert, Thomas Lumley, Paulo Chaves, Curt D. Furberg, Lewis Kuller, Bruce M. Psaty

    Résumé Résumé Plan Plan  
  • ·Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure

    Page :471-477

    Robert L. Fitzgerald, Rosemary Cremo, Nancy Gardetto, Albert Chiu, Paul Clopton, Vikas Bhalla, Alan S. Maisel

    Résumé Résumé Plan Plan  
  • ·Comparative effects of nicorandil with isosorbide mononitrate on cardiac sympathetic nerve activity and left ventricular function in patients with ischemic cardiomyopathy

    Page :477.e1

    Shu Kasama, Takuji Toyama, Takashi Hatori, Hisao Kumakura, Yoshiaki Takayama, Shuichi Ichikawa, Tadashi Suzuki, Masahiko Kurabayashi

    Résumé Résumé Plan Plan  
  • ·A prospective evaluation of the effect of simvastatin on heart rate variability in non-ischemic cardiomyopathy

    Page :478-483

    Philip J. Gentlesk, Thomas Wiley, Allen J. Taylor

    Résumé Résumé Plan Plan  
  • ·Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure

    Page :484-487

    Jacob George, Shuki Patal, Dov Wexler, Arie Roth, David Sheps, Gad Keren

    Résumé Résumé Plan Plan  
  • ·Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: Further evidence for the inflammatory basis of atherosclerosis

    Page :488-499

    Gemma Satterthwaite, Sheila E. Francis, Kim Suvarna, Stephen Blakemore, Chantelle Ward, Don Wallace, Martin Braddock, David Crossman

    Résumé Résumé Plan Plan   
  • ·Creation of a large-scale genetic data bank for cardiovascular association studies

    Page :500-506

    Ramtin Agah, Stephen Ellis, Sue Chase, Mark Henderson, Lisa Mlady, Gurunathan Murugesan, Raymond Tubbs, Kandice Marchant, Ilka Warshawsky, Colleen Rouse, Kathy Hughes, Patricia Welch, Eric J. Topol

    Résumé Résumé Plan Plan   
  • ·The relationship between electrical axis by 12-lead electrocardiogram and anatomical axis of the heart by cardiac magnetic resonance in healthy subjects

    Page :507-512

    Henrik Engblom, John E. Foster, Thomas N. Martin, Bjoern Groenning, Olle Pahlm, Henry J. Dargie, Galen S. Wagner, Håkan Arheden

    Résumé Résumé Plan Plan  
  • ·The prevalence of bicuspid aortic valve in newborns by echocardiographic screening

    Page :513-515

    Ercan Tutar, Filiz Ekici, Semra Atalay, Nazire Nacar

    Résumé Résumé Plan Plan  
  • ·Prognostic value of the Duke Treadmill Score in diabetic patients

    Page :516-521

    Dhanunjaya R. Lakkireddy, Jyothi Bhakkad, Hema L. Korlakunta, Kay Ryschon, Xuedong Shen, Aryan N. Mooss, Syed M. Mohiuddin

    Résumé Résumé Plan Plan  
  • ·The Doppler myocardial performance index during low-dose dobutamine echocardiography predicts mortality and left ventricular dilation after a first acute myocardial infarction

    Page :522-529

    Betina Nørager, Mirza Husic, Jacob E. Møller, Patricia A. Pellikka, Christopher P. Appleton, Kenneth Egstrup

    Résumé Résumé Plan Plan  
  • ·Magnetic resonance angiography of coronary arteries with a 3-dimensional magnetization-prepared true fast imaging with steady-state precession sequence compared with conventional coronary angiography

    Page :530-535

    Nina Man-ching So, Wynnie Wai-man Lam, Debiao Li, Anna Kin-Yin Chan, John Elsby Sanderson, Constantine Metreweli

    Résumé Résumé Plan Plan  
  • ·Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients

    Page :536-542

    Alberto Berenguer, Vicente Mainar, Pascual Bordes, Jose Valencia, Silvia Gómez, Teresa Lozano

    Résumé Résumé Plan Plan  
  • ·Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction—the RADIAL-AMI pilot randomized trial

    Page :543-549

    Warren J. Cantor, Geoff Puley, Madhu K. Natarajan, Vlad Dzavik, Mina Madan, Anne Fry, Hahn Hoe Kim, James L. Velianou, Nurry Pirani, Bradley H. Strauss, Robert J. Chisholm

    Résumé Résumé Plan Plan  
  • ·Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting

    Page :550-556

    Siegmund Braun, Gjin Ndrepepa, Nicolas von Beckerath, Julinda Mehilli, Olga Gorchakova, Wolfgang Vogt, Albert Schömig, Adnan Kastrati

    Résumé Résumé Plan Plan  
  • ·Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty

    Page :557-562

    Giuseppe De Luca, Arnoud W.J. van't Hof, Jan Paul Ottervanger, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Jan-Henk E. Dambrink, Felix Zijlstra, Menko-Jan de Boer, Harry Suryapranata

    Résumé Résumé Plan Plan  
  • ·Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction

    Page :563-568

    Leonardo De Luca, Paola Proietti, Annalisa Celotto, Chiara Bucciarelli-Ducci, Giulia Benedetti, Angelo Di Roma, Gennaro Sardella, Igino Genuini, Francesco Fedele

    Résumé Résumé Plan Plan  
  • ·Cilostazol improves long-term outcomes after coronary stent implantation

    Page :568.e1

    Yaling Han, Shouli Wang, Yi Li, Quanmin Jing, Yingyan Ma, Jie Deng, Guitang Yang, Haibo Yu, Junbo Ge

    Plan Plan  
  • ·Temporal variation in inhospital mortality with percutaneous coronary intervention: A report from the National Heart, Lung and Blood Institute Dynamic Registry

    Page :569-576

    Warren K. Laskey, Faith Selzer, David R. Holmes, Robert L. Wilensky, Howard A. Cohen, David O. Williams, Kevin E. Kip, Katherine M. Detre, on behalf of the NHLBI Dynamic Registry Investigators

    Résumé Résumé Plan Plan  
  • ·Comparison of angiographic and clinical outcomes between rotational atherectomy and cutting balloon angioplasty followed by radiation therapy with a rhenium 188–mercaptoacetyltriglycine–filled balloon in the treatment of diffuse in-stent restenosis

    Page :577-582

    Seung-Whan Lee, Seong-Wook Park, Myeong-Ki Hong, Young-Hak Kim, Ki Hoon Han, Dae Hyuk Moon, Seung Jun Oh, Cheol Whan Lee, Jae-Joong Kim, Seung-Jung Park

    Résumé Résumé Plan Plan
  • ·Can the wrong statistic be bad for health? Improving the reporting of door-to-needle time performance in acute myocardial infarction

    Page :583-587

    Michael J. Schull, Marian Vermeulen, Linda Donovan, Alice Newman, Jack V. Tu

    Résumé Résumé Plan Plan
  • ·Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation

    Page :588-594

    Kei Inai, Toshio Nakanishi, Makoto Nakazawa

    Résumé Résumé Plan Plan  
  • ·Gauging the treatment gap in dyslipidemia: Findings from the 1999-2000 National Health and Nutrition Examination Survey

    Page :595-601

    David Klingman, Setareh A. Williams, Joshua S. Benner, Timothy W. Smith, Jeonghoon Ahn, John C. O'Donnell

    Résumé Résumé Plan Plan
  • ·Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting

    Page :602-609

    George D. Bishop, Divjyot Kaur, Vicky L.M. Tan, Yeow-Leng Chua, Siok-Moey Liew, Koon-Hou Mak

    Plan Plan  
  • ·Doppler tissue imaging: A reliable method for estimation of left ventricular filling pressure in patients with mitral regurgitation

    Page :610-615

    Eustachio Agricola, Maurizio Galderisi, Michele Oppizzi, Giulio Melisurgo, Fabio Airoldi, Alberto Margonato

    Résumé Résumé Plan Plan